Benzinga | Aug 5, 2021 08:10AM EDT

Intellia Therapeutics Q2 EPS $(1.01) Misses $(0.63) Estimate, Sales $6.55M Miss $11.89M Estimate

Intellia Therapeutics (NASDAQ:NTLA) reported quarterly losses of $(1.01) per share which missed the analyst consensus estimate of $(0.63) by 60.32 percent. This is a 65.57 percent decrease over losses of $(0.61) per share from the same period last year. The company reported quarterly sales of $6.55 million which missed the analyst consensus estimate of $11.89 million by 44.91 percent. This is a 59.72 percent decrease over sales of $16.26 million the same period last year.